Idera Pharmaceuticals Announces FDA Authorization To go on With A Phase ii ... TheStreet.com (press release) “We are pleased to have the FDA's due process that we can go on with a Phase ii clinical trial of IMO-3100 in patients with disease of the skin ,” said Sudhir Agrawal, D.Phil., Chairman and primary Executive Officer of Idera. “We are now preparing for this Phase ... and more » Link To Article
No comments:
Post a Comment